Free tool
Healthcare stocks
We cover 1,027 companies in the Healthcare sector. The median market value in the group is $411.56M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +1.20%. 56% of the 972 with a 200-day average trade above it. Price change over the past year runs from −72.7% to +182.0% across the middle 80 percent of the group, with a median of +7.0%. Among those 1,000, 6 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,027 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.85% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| VRTX | Vertex Pharmaceuticals Incorporated | $140.04B | Large cap | +42.14% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −20.62% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| SNY | Sanofi | $110.27B | Large cap | −3.11% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.82B | Large cap | +46.21% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| BSX | Boston Scientific Corporation | $72.26B | Large cap | −52.56% |
| ARGX | argenx SE | $63.78B | Large cap | +50.52% |
| MRNA | Moderna, Inc. | $63.41B | Large cap | +526.55% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.38% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| MDLN | Medline Inc. | $46.69B | Large cap | −13.07% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.40B | Large cap | +110.26% |
| IDXX | IDEXX Laboratories, Inc. | $43.39B | Large cap | −14.24% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| IQV | IQVIA Holdings Inc. | $42.70B | Large cap | +37.97% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% |
| WAT | Waters Corporation | $40.69B | Large cap | +38.63% |
| VEEV | Veeva Systems Inc. | $40.09B | Large cap | −13.47% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RPRX | Royalty Pharma plc | $35.44B | Large cap | +75.10% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| ILMN | Illumina, Inc. | $33.97B | Large cap | +125.76% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $33.62B | Large cap | −0.78% |
| BIIB | Biogen Inc. | $32.62B | Large cap | +61.90% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −45.88% |
| CNC | Centene Corporation | $32.11B | Large cap | +123.52% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.72% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| INSM | Insmed Incorporated | $27.07B | Large cap | −3.45% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% |
| ROIV | Roivant Sciences Ltd. | $26.26B | Large cap | +213.32% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +54.57% |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% |
| VTRS | Viatris Inc. | $19.20B | Large cap | +62.88% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| MEDP | Medpace Holdings, Inc. | $17.31B | Large cap | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +108.87% |
| ASND | Ascendis Pharma A/S | $16.59B | Large cap | +32.89% |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | Large cap | +70.01% |
| SOLV | Solventum Corporation | $15.59B | Large cap | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $15.59B | Large cap | +14.46% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $14.21B | Large cap | +81.37% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| ICLR | ICON Public Limited Company | $13.38B | Large cap | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $13.36B | Large cap | +79.56% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.80B | Large cap | +13.03% |
| PEN | Penumbra, Inc. | $12.75B | Large cap | +22.79% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +329.16% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +51.39% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $12.20B | Large cap | +41.03% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.83B | Large cap | +24.24% |
| DVA | DaVita Inc. | $11.41B | Large cap | +29.47% |
| ALGN | Align Technology, Inc. | $11.34B | Large cap | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +137.67% |
| TECH | Bio-Techne Corporation | $11.27B | Large cap | +28.12% |
| GMED | Globus Medical, Inc. | $11.14B | Large cap | +35.16% |
| CYTK | Cytokinetics, Incorporated | $10.77B | Large cap | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $10.76B | Large cap | +76.67% |
| GKOS | Glaukos Corporation | $10.70B | Large cap | +98.13% |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +52.01% |
| KRYS | Krystal Biotech, Inc. | $10.54B | Large cap | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $10.45B | Large cap | +31.26% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.44% |
| MOH | Molina Healthcare, Inc. | $10.42B | Large cap | +13.96% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| ABVX | ABIVAX Société Anonyme | $10.29B | Large cap | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $10.28B | Large cap | +684.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +49.84% |
| HSIC | Henry Schein, Inc. | $10.21B | Large cap | +30.93% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +265.05% |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% |
| PODD | Insulet Corporation | $9.92B | Mid cap | −56.52% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| AVTR | Avantor, Inc. | $9.75B | Mid cap | +9.16% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +85.10% |
| TWST | Twist Bioscience Corporation | $9.50B | Mid cap | +452.83% |
| SYRE | Spyre Therapeutics, Inc. | $9.32B | Mid cap | +547.53% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +100.62% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +182.02% |
| IMVT | Immunovant, Inc. | $8.95B | Mid cap | +192.14% |
| HQY | HealthEquity, Inc. | $8.83B | Mid cap | +20.55% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.48B | Mid cap | +96.32% |
| TXG | 10x Genomics, Inc. | $8.43B | Mid cap | +359.99% |
| ALKS | Alkermes plc | $8.26B | Mid cap | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% |
| HIMS | Hims & Hers Health, Inc. | $7.41B | Mid cap | −26.15% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +63.19% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $7.09B | Mid cap | +74.77% |
| PACS | PACS Group, Inc. | $7.00B | Mid cap | +272.69% |
| CGON | CG Oncology, Inc. | $7.00B | Mid cap | +210.58% |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% |
| BLTE | Belite Bio, Inc | $6.51B | Mid cap | +154.13% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.24B | Mid cap | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.17B | Mid cap | +142.74% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.72% |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.13B | Mid cap | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +378.90% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $6.02B | Mid cap | +354.92% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| CRSP | CRISPR Therapeutics AG | $5.89B | Mid cap | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $5.85B | Mid cap | +58.42% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.62B | Mid cap | +77.42% |
| MMED | MiniMed Group, Inc. | $5.60B | Mid cap | +2.33% |
| SHC | Sotera Health Company | $5.57B | Mid cap | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | +3.32% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.23B | Mid cap | +20.73% |
| HAE | Haemonetics Corporation | $4.93B | Mid cap | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +102.62% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +209.16% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +127.83% |
| WAY | Waystar Holding Corp. | $4.64B | Mid cap | −32.56% |
| ICUI | ICU Medical, Inc. | $4.56B | Mid cap | +44.85% |
| DOCS | Doximity, Inc. | $4.51B | Mid cap | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $4.48B | Mid cap | +205.89% |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| NVST | Envista Holdings Corporation | $4.39B | Mid cap | +30.07% |
| LIVN | LivaNova PLC | $4.37B | Mid cap | +40.92% |
| HTFL | Heartflow, Inc. | $4.34B | Mid cap | +67.19% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.24B | Mid cap | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.17B | Mid cap | +340.71% |
| LEGN | Legend Biotech Corporation | $4.14B | Mid cap | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −25.71% |
| ABCL | AbCellera Biologics Inc. | $4.05B | Mid cap | +195.51% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $3.99B | Mid cap | +32.19% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $3.96B | Mid cap | −4.26% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +52.72% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +168.82% |
| QURE | uniQure N.V. | $3.54B | Mid cap | +228.30% |
| OPCH | Option Care Health, Inc. | $3.54B | Mid cap | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $3.50B | Mid cap | +197.94% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.33B | Mid cap | +275.00% |
| MBX | MBX Biosciences, Inc. | $3.30B | Mid cap | +394.02% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +10.69% |
| WRBY | Warby Parker Inc. | $3.24B | Mid cap | −0.61% |
| CLDX | Celldex Therapeutics, Inc. | $3.24B | Mid cap | +87.96% |
| TMDX | TransMedics Group, Inc. | $3.23B | Mid cap | −18.59% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +88.75% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.20B | Mid cap | +26.21% |
| IRON | Disc Medicine, Inc. | $3.16B | Mid cap | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +58.44% |
| ALMS | Alumis Inc. | $2.98B | Mid cap | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +82.91% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $2.82B | Mid cap | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $2.78B | Mid cap | +34.73% |
| RGC | Regencell Bioscience Holdings Limited | $2.74B | Mid cap | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +237.59% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.62B | Mid cap | +2.09% |
| PHVS | Pharvaris N.V. | $2.62B | Mid cap | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −9.60% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| PGEN | Precigen, Inc. | $2.60B | Mid cap | +82.91% |
| TRVI | Trevi Therapeutics, Inc. | $2.56B | Mid cap | +146.57% |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +17.16% |
| BHC | Bausch Health Companies Inc. | $2.50B | Mid cap | −7.81% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +316.68% |
| ATRC | AtriCure, Inc. | $2.48B | Mid cap | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | Mid cap | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $2.46B | Mid cap | +249.76% |
| BFLY | Butterfly Network, Inc. | $2.41B | Mid cap | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $2.39B | Mid cap | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +42.20% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $2.32B | Mid cap | +78.70% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.32B | Mid cap | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $2.29B | Mid cap | +50.09% |
| GENB | Generate Biomedicines, Inc. | $2.27B | Mid cap | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.27B | Mid cap | +4.09% |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% |
| ADUS | Addus HomeCare Corporation | $2.26B | Mid cap | +3.81% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.23B | Mid cap | +38.03% |
| VCEL | Vericel Corporation | $2.21B | Mid cap | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $2.20B | Mid cap | +103.93% |
| CLOV | Clover Health Investments, Corp. | $2.19B | Mid cap | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
| BHVN | Biohaven Ltd. | $2.17B | Mid cap | −3.75% |
| STOK | Stoke Therapeutics, Inc. | $2.16B | Mid cap | +77.32% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +77.45% |
| KLRA | Kailera Therapeutics, Inc. | $2.14B | Mid cap | −31.73% |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $2.14B | Mid cap | +195.71% |
| HCM | HUTCHMED (China) Limited | $2.13B | Mid cap | −23.04% |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% |
| PIII | P3 Health Partners Inc. | $2.06B | Mid cap | +35.72% |
| CMPS | COMPASS Pathways plc | $2.06B | Mid cap | +224.89% |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| TSHA | Taysha Gene Therapies, Inc. | $2.02B | Mid cap | +112.33% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
| SRPT | Sarepta Therapeutics, Inc. | $2.00B | Small cap | +4.76% |
| GHRS | GH Research PLC | $1.99B | Small cap | +119.42% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +9.98% |
| SNDA | Sonida Senior Living, Inc. | $1.97B | Small cap | +57.21% |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $1.95B | Small cap | −9.02% |
| LKFT | Lakefront Biotherapeutics NV | $1.94B | Small cap | −5.53% |
| SEPN | Septerna, Inc. | $1.93B | Small cap | +245.32% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.91B | Small cap | −26.29% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +18.72% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% |
| ASTH | Astrana Health, Inc. | $1.87B | Small cap | +25.66% |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −39.02% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.11% |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −18.51% |
| ETON | Eton Pharmaceuticals, Inc. | $1.80B | Small cap | +268.93% |
| ALVO | Alvotech | $1.80B | Small cap | −39.30% |
| INSP | Inspire Medical Systems, Inc. | $1.77B | Small cap | −34.28% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.74B | Small cap | −16.24% |
| FTRE | Fortrea Holdings Inc. | $1.74B | Small cap | +106.21% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +335.60% |
| AVLN | Avalyn Pharma Inc. | $1.69B | Small cap | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +128.55% |
| ABSI | Absci Corporation | $1.65B | Small cap | +279.13% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +580.25% |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% |
| AGL | agilon health, inc. | $1.61B | Small cap | +178.58% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.61B | Small cap | +137.42% |
| ARDT | Ardent Health, Inc. | $1.59B | Small cap | −10.95% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.59B | Small cap | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $1.59B | Small cap | +122.42% |
| OMCL | Omnicell, Inc. | $1.58B | Small cap | +0.39% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.58B | Small cap | +51.92% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +48.10% |
| LBRX | LB Pharmaceuticals Inc | $1.57B | Small cap | +182.08% |
| AAPG | Ascentage Pharma Group Internat | $1.57B | Small cap | −61.38% |
| NVAX | Novavax, Inc. | $1.56B | Small cap | +25.53% |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −5.45% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.14% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.50B | Small cap | +83.48% |
| SDGR | Schrödinger, Inc. | $1.50B | Small cap | +2.30% |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +197.55% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% |
| ENOV | Enovis Corporation | $1.48B | Small cap | −17.46% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +14.00% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.43% |
| AZTA | Azenta, Inc. | $1.45B | Small cap | +7.96% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +107.85% |
| ATEC | Alphatec Holdings, Inc. | $1.43B | Small cap | −41.10% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +96.83% |
| ANRO | Alto Neuroscience, Inc. | $1.42B | Small cap | +821.57% |
| OMER | Omeros Corporation | $1.40B | Small cap | +343.22% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.40B | Small cap | +43.76% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +176.46% |
| DRTS | Alpha Tau Medical Ltd. | $1.36B | Small cap | +357.94% |
| MNKD | MannKind Corporation | $1.34B | Small cap | +6.67% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +55.24% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.52% |
| AMN | AMN Healthcare Services, Inc. | $1.31B | Small cap | +63.90% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +17.66% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −41.72% |
| CRON | Cronos Group Inc. | $1.29B | Small cap | +35.52% |
| SPTX | Seaport Therapeutics, Inc. | $1.29B | Small cap | +25.15% |
| AORT | Artivion, Inc. | $1.29B | Small cap | −39.45% |
| NUTX | Nutex Health Inc. | $1.28B | Small cap | +110.14% |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% |
| ODTX | Odyssey Therapeutics, Inc. | $1.26B | Small cap | +59.74% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% |
| CERT | Certara, Inc. | $1.24B | Small cap | −24.70% |
| PRCT | PROCEPT BioRobotics Corporation | $1.24B | Small cap | −45.05% |
| SANA | Sana Biotechnology, Inc. | $1.23B | Small cap | +22.39% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% |
| GDRX | GoodRx Holdings, Inc. | $1.17B | Small cap | −18.24% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +115.43% |
| STAA | STAAR Surgical Company | $1.17B | Small cap | −15.68% |
| USPH | U.S. Physical Therapy, Inc. | $1.15B | Small cap | −7.75% |
| SVRA | Savara Inc. | $1.15B | Small cap | +78.34% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.14B | Small cap | −34.83% |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% |
| TDOC | Teladoc Health, Inc. | $1.12B | Small cap | −19.30% |
| IRMD | IRADIMED CORPORATION | $1.11B | Small cap | +24.31% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% |
| IVA | Inventiva S.A. | $1.11B | Small cap | +0.54% |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% |
| AVTX | Avalo Therapeutics, Inc. | $1.06B | Small cap | +110.00% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +107.08% |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −47.18% |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +48.57% |
| CLYM | Climb Bio Inc | $1.02B | Small cap | +619.35% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| PCRX | Pacira BioSciences, Inc. | $1.00B | Small cap | +0.67% |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% |
| SLDB | Solid Biosciences Inc. | $982.18M | Small cap | +76.61% |
| DSGN | Design Therapeutics, Inc. | $981.28M | Small cap | +201.54% |
| ANNX | Annexon, Inc. | $976.33M | Small cap | +139.53% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −37.62% |
| IMMX | Immix Biopharma, Inc. | $968.90M | Small cap | +589.05% |
| BVS | Bioventus Inc. | $961.74M | Small cap | +89.25% |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% |
| HELP | Cybin D/B/A Helus Pharma | $951.24M | Small cap | +92.90% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +52.91% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −26.32% |
| ACRS | Aclaris Therapeutics, Inc. | $928.83M | Small cap | +263.06% |
| CBLL | CeriBell, Inc. | $919.16M | Small cap | +109.35% |
| SGP | SpyGlass Pharma, Inc. | $889.72M | Small cap | +0.76% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +737.80% |
| TBPH | Theravance Biopharma, Inc. | $883.14M | Small cap | +23.45% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +97.74% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +10.83% |
| SIBN | SI-BONE, Inc. | $866.59M | Small cap | +21.74% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +140.27% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% |
| INMD | InMode Ltd. | $864.89M | Small cap | +3.16% |
| COLL | Collegium Pharmaceutical, Inc. | $851.55M | Small cap | −29.15% |
| FDMT | 4D Molecular Therapeutics, Inc. | $850.21M | Small cap | +133.23% |
| SLN | Silence Therapeutics plc | $849.65M | Small cap | +170.16% |
| AHG | Akso Health Group | $843.17M | Small cap | −44.40% |
| HSTM | HealthStream, Inc. | $841.53M | Small cap | +4.49% |
| PHAR | Pharming Group N.V. | $833.06M | Small cap | −19.75% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +47.91% |
| NGNE | Neurogene Inc. | $817.26M | Small cap | +104.40% |
| ACHV | Achieve Life Sciences, Inc. | $817.05M | Small cap | +146.83% |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +710.87% |
| DRUG | Bright Minds Biosciences Inc. | $779.96M | Small cap | +90.62% |
| VREX | Varex Imaging Corporation | $779.74M | Small cap | +62.28% |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% |
| ALLO | Allogene Therapeutics, Inc. | $749.72M | Small cap | +87.07% |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% |
| AHCO | AdaptHealth Corp. | $745.58M | Small cap | −40.63% |
| TECX | Tectonic Therapeutic, Inc. | $737.21M | Small cap | +53.48% |
| SOPH | SOPHiA GENETICS SA | $736.36M | Small cap | +150.72% |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $725.40M | Small cap | +245.67% |
| OCS | Oculis Holding AG | $719.64M | Small cap | −27.15% |
| ASMB | Assembly Biosciences, Inc. | $718.32M | Small cap | +32.72% |
| ZVRA | Zevra Therapeutics, Inc. | $714.98M | Small cap | +28.63% |
| PHAT | Phathom Pharmaceuticals, Inc. | $711.93M | Small cap | −25.15% |
| PHR | Phreesia, Inc. | $711.64M | Small cap | −62.09% |
| SSII | SS Innovations International, Inc. | $711.37M | Small cap | −49.14% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +18.95% |
| PROK | ProKidney Corp. | $690.59M | Small cap | −26.38% |
| AGMB | AgomAb Therapeutics NV | $690.46M | Small cap | −4.30% |
| GMRS | GMR Solutions Inc. | $686.08M | Small cap | −9.16% |
| GYRE | Gyre Therapeutics, Inc. | $682.86M | Small cap | −18.54% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% |
| OABI | OmniAb, Inc. | $677.52M | Small cap | +185.89% |
| PRME | Prime Medicine, Inc. | $672.91M | Small cap | +5.40% |
| EVO | Evotec SE | $671.69M | Small cap | −47.06% |
| TLRY | Tilray Brands, Inc. | $671.39M | Small cap | −66.04% |
| CRMD | CorMedix Inc. | $667.20M | Small cap | −37.65% |
| ANGO | AngioDynamics, Inc. | $651.81M | Small cap | +64.77% |
| AUTL | Autolus Therapeutics plc | $649.44M | Small cap | +52.50% |
| VALN | Valneva SE | $642.90M | Small cap | −28.10% |
| CTNM | Contineum Therapeutics, Inc. | $641.44M | Small cap | +64.10% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −21.16% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +20.75% |
| SGMT | Sagimet Biosciences Inc. | $639.61M | Small cap | +45.34% |
| CTEV | Claritev Corporation | $637.90M | Small cap | −47.44% |
| MDXG | MiMedx Group, Inc. | $632.60M | Small cap | −38.70% |
| CBIO | Crescent Biopharma, Inc. | $630.33M | Small cap | +15.65% |
| ARVN | Arvinas, Inc. | $610.71M | Small cap | +28.34% |
| ZURA | Zura Bio Limited | $605.64M | Small cap | +208.29% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −5.60% |
| AQST | Aquestive Therapeutics, Inc. | $602.46M | Small cap | +31.61% |
| ENTX | Entera Bio Ltd. | $600.80M | Small cap | +77.95% |
| CTKB | Cytek Biosciences, Inc. | $595.32M | Small cap | +11.44% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | −0.67% |
| DCTH | Delcath Systems, Inc. | $587.10M | Small cap | +55.37% |
| WEAV | Weave Communications, Inc. | $583.19M | Small cap | −4.33% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +20.79% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +317.38% |
| BWAY | BrainsWay Ltd. | $570.28M | Small cap | +87.89% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −57.66% |
| OVID | Ovid Therapeutics Inc. | $568.32M | Small cap | +155.26% |
| EVH | Evolent Health, Inc. | $552.86M | Small cap | −49.59% |
| FLGT | Fulgent Genetics, Inc. | $548.93M | Small cap | −7.34% |
| CERS | Cerus Corporation | $548.15M | Small cap | +112.50% |
| SRTA | Strata Critical Medical, Inc. | $547.61M | Small cap | +39.10% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +132.02% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +102.52% |
| TCMD | Tactile Systems Technology, Inc. | $529.16M | Small cap | +81.38% |
| MPLT | MapLight Therapeutics, Inc. | $526.85M | Small cap | −31.62% |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% |
| CLPT | ClearPoint Neuro, Inc. | $517.35M | Small cap | +61.52% |
| CCCC | C4 Therapeutics, Inc. | $516.71M | Small cap | +66.01% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +78.67% |
| CGC | Canopy Growth Corporation | $508.85M | Small cap | −25.69% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −37.43% |
| EDIT | Editas Medicine, Inc. | $503.74M | Small cap | +20.59% |
| SENS | Senseonics Holdings, Inc. | $503.36M | Small cap | +4.39% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −31.83% |
| KMDA | Kamada Ltd. Ordinary Shares | $497.90M | Small cap | +26.12% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +41.87% |
| RLMD | Relmada Therapeutics, Inc. | $489.61M | Small cap | +635.58% |
| NRC | NRC Health | $487.51M | Small cap | +48.16% |
| NPCE | NeuroPace, Inc. | $486.03M | Small cap | +63.70% |
| QTTB | Q32 Bio Inc. | $485.84M | Small cap | +728.43% |
| PRTA | Prothena Corporation plc | $483.59M | Small cap | +12.41% |
| RZLT | Rezolute, Inc. | $482.42M | Small cap | −28.43% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +25.61% |
| OCGN | Ocugen, Inc. | $474.75M | Small cap | +34.62% |
| PACB | Pacific Biosciences of California, Inc. | $472.46M | Small cap | +15.15% |
| PBYI | Puma Biotechnology, Inc. | $470.77M | Small cap | +86.77% |
| BIOA | BioAge Labs, Inc. | $464.02M | Small cap | +124.17% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.62% |
| CMPX | Compass Therapeutics, Inc. | $455.62M | Small cap | −16.23% |
| MASS | 908 Devices Inc. | $454.67M | Small cap | +75.44% |
| BNTC | Benitec Biopharma Inc. | $447.29M | Small cap | −1.44% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +48.36% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +11.83% |
| CARL | Carlsmed, Inc. | $431.38M | Small cap | +12.06% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | −3.92% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +10.09% |
| EYPT | EyePoint, Inc. | $419.85M | Small cap | −56.82% |
| RCKT | Rocket Pharmaceuticals, Inc. | $414.95M | Small cap | +6.78% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | +4.79% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.